- Home
- IDYA vs LU Comparison
IDYA vs LU Comparison
Compare IDYA & LU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IDYA | LU |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.3B |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | IDYA | LU |
|---|---|---|
| Price | $31.40 | $1.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $51.21 | N/A |
| AVG Volume (30 Days) | 824.6K | ★ 1.8M |
| Earning Date | 05-05-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.90 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $218,710,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $191.08 | $22.52 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3024.43 | N/A |
| 52 Week Low | $13.45 | $1.73 |
| 52 Week High | $39.28 | $4.57 |
Technical Indicators
Market Signals| Indicator | IDYA | LU |
|---|---|---|
| Relative Strength Index (RSI) | 44.31 | 23.05 |
| Support Level | $29.15 | N/A |
| Resistance Level | $35.47 | $2.77 |
| Average True Range (ATR) | 1.47 | 0.10 |
| MACD | -0.26 | -0.03 |
| Stochastic Oscillator | 30.38 | 9.84 |
Price Performance
Historical ComparisonAbout IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
About LU Lufax Holding Ltd each representing two (2)
Lufax Holding Ltd is a technology-empowered personal financial services platform in China. The company address the large unmet demand for personal lending among small business owners as well as salaried workers in China and provides tailor-made wealth management solutions to China's middle class and affluent population. Its platform has two hubs namely Retail Credit Facilitation Hub and Wealth Management Hub.